| The COVID-19 from Neurological Overview | Fettah EREN, Semih AYTA, Şevki ŞAHİN, Erdem YAKA, Demet İLHAN ALGIN, Oğuz Osman ERDİNÇ, Aybala Neslihan ALAGÖZ, Türkan ACAR, Hacer DURMUŞ TEKÇE, Şerefnur ÖZTÜRK, Ömer KARADAŞ, Cavit BOZ, Ayşe Deniz ELMALI, Demet ÖZBABALIK ADAPINAR, Atilla ÖZCAN ÖZDEMİR, Hakan EKMEKÇİ, Nazire AFŞAR, Ayşe BORA TOKÇAER | 58–108 |
| Update on Therapeutic Strategies for Atypical Parkinsonian Syndromes | Mehdİ MAGHBOOLI, Vida MOHAMMADZADEH, Mehran YOUSEFI | 112–121 |
| Aquaporin-4 Gene Polymorphisms in Neuromyelitis Optica and Recurrent Optic Neuritis | Elif Sinem İPLİK, Cem İsmail KÜÇÜKALİ, Erdem TÜZÜN, Canan ULUSOY, Murat KÜRTÜNCÜ, Arman ÇAKAR | 122–125 |
| Factors Predicting Falls in Parkinson’s Disease: Investigation of Motor, Non-motor Findings and Different Dual Task Activities | Zeynep TÜFEKÇİOĞLU, Burcu ERSÖZ HÜSEYİNSİNOĞLU, Emrah ZİREK, Başar BİLGİÇ, Hakan GÜRVİT, Haşmet HANAĞASI | 126–132 |
| The Relationship Between Mean Platelet Volume, Platelet Count, Platelet Lymphocyte Ratio, and Recanalization Success in First-pass Thrombectomy of Middle Cerebral Artery Occlusions | Nihat ŞENGEZE, Semih GİRAY | 133–137 |
| Thrombolytic Therapy for Stroke in Turkey: Meta-analysis of Published Case Series | Mehmet Akif TOPÇUOĞLU, Mustafa ÇETİNER, Ethem Murat ARSAVA | 138–141 |
| Evaluation of Patients Diagnosed as Having Acute Stroke in the Emergency Department: Two-year Analysis | Oya KALAYCIOĞLU, Kaan ÇELİK, Tamer ÇOLAK, Beliz Öztok TEKTEN, Halil İlker YENCİLEK | 142–148 |
| Awareness of Stroke in the Population Presenting to Outpatient Clinics at a Tertiary Health Institution | Buket Tuğan YILDIZ, Mustafa GÖKÇE, Hamza ŞAHİN | 149–152 |
| Palliative Care Requirement in Neurologic Diseases | Gülhan SARIÇAM, Kadriye KAHVECİ, Doğan AKDOĞAN | 153–159 |
| The Efficacy of Acyclovir in Childhood Bell’s Palsy | Gürkan GÜRBÜZ | 160–164 |
| Acquired Immune Deficiency Syndrome Showing Its First Symptom with Nervous System Involvement | Eylem DEĞİRMENCİ, Selda SAYIN KUTLU, Zeynep ÜNLÜTÜRK |